221 related articles for article (PubMed ID: 38498070)
1. Systematic review of randomized controlled trials of topicals for actinic keratosis field therapy.
Patel P; Wang J; Bitterman D; Mineroff J; Austin E; Jagdeo J
Arch Dermatol Res; 2024 Mar; 316(4):108. PubMed ID: 38498070
[TBL] [Abstract][Full Text] [Related]
2. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
[TBL] [Abstract][Full Text] [Related]
3. Fluorouracil is Superior to Other Commonly Used Topical Agents for the Treatment of Field Cancerization.
Ouchene L; Litvinov IV; Netchiporouk E
J Cutan Med Surg; 2019; 23(4):455-456. PubMed ID: 31337239
[No Abstract] [Full Text] [Related]
4. Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
Mohney L; Singh R; Grada A; Feldman S
J Drugs Dermatol; 2022 Jan; 21(1):60-65. PubMed ID: 35005863
[TBL] [Abstract][Full Text] [Related]
5. Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review.
Aggarwal I; Puyana C; Chandan N; Jetter N; Tsoukas M
Am J Clin Dermatol; 2024 May; 25(3):391-405. PubMed ID: 38351246
[TBL] [Abstract][Full Text] [Related]
6. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
Philipp-Dormston WG
Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Cunningham TJ; Tabacchi M; Eliane JP; Tuchayi SM; Manivasagam S; Mirzaalian H; Turkoz A; Kopan R; Schaffer A; Saavedra AP; Wallendorf M; Cornelius LA; Demehri S
J Clin Invest; 2017 Jan; 127(1):106-116. PubMed ID: 27869649
[TBL] [Abstract][Full Text] [Related]
8. Interventions for actinic keratoses.
Gupta AK; Paquet M; Villanueva E; Brintnell W
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD004415. PubMed ID: 23235610
[TBL] [Abstract][Full Text] [Related]
9. Field cancerization: Treatment.
Cornejo CM; Jambusaria-Pahlajani A; Willenbrink TJ; Schmults CD; Arron ST; Ruiz ES
J Am Acad Dermatol; 2020 Sep; 83(3):719-730. PubMed ID: 32387663
[TBL] [Abstract][Full Text] [Related]
10. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
[TBL] [Abstract][Full Text] [Related]
11. Treatment of actinic keratosis: a systematic review.
Worley B; Harikumar V; Reynolds K; Dirr MA; Christensen RE; Anvery N; Yi MD; Poon E; Alam M
Arch Dermatol Res; 2023 Jul; 315(5):1099-1108. PubMed ID: 36454335
[TBL] [Abstract][Full Text] [Related]
12. Guidelines of care for the management of actinic keratosis.
Eisen DB; Asgari MM; Bennett DD; Connolly SM; Dellavalle RP; Freeman EE; Goldenberg G; Leffell DJ; Peschin S; Sligh JE; Wu PA; Frazer-Green L; Malik S; Schlesinger TE
J Am Acad Dermatol; 2021 Oct; 85(4):e209-e233. PubMed ID: 33820677
[TBL] [Abstract][Full Text] [Related]
13. Guidelines of care for the management of actinic keratosis: Executive summary.
Eisen DB; Asgari MM; Bennett DD; Connolly SM; Dellavalle RP; Freeman EE; Goldenberg G; Leffell DJ; Peschin S; Sligh JE; Wu PA; Frazer-Green L; Malik S; Schlesinger TE
J Am Acad Dermatol; 2021 Oct; 85(4):945-955. PubMed ID: 34111497
[TBL] [Abstract][Full Text] [Related]
14. Field Cancerization Therapies for Management of Actinic Keratosis: A Narrative Review.
Jetter N; Chandan N; Wang S; Tsoukas M
Am J Clin Dermatol; 2018 Aug; 19(4):543-557. PubMed ID: 29582369
[TBL] [Abstract][Full Text] [Related]
15. In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.
Ulrich M; Alarcon I; Malvehy J; Puig S
Dermatology; 2015; 230(3):193-8. PubMed ID: 25721522
[TBL] [Abstract][Full Text] [Related]
16. Focused update: Guidelines of care for the management of actinic keratosis.
Eisen DB; Dellavalle RP; Frazer-Green L; Schlesinger TE; Shive M; Wu PA
J Am Acad Dermatol; 2022 Aug; 87(2):373-374.e5. PubMed ID: 35439607
[TBL] [Abstract][Full Text] [Related]
17. Topical therapy for actinic keratoses: current and evolving therapies.
Weinberg JM
Rev Recent Clin Trials; 2006 Jan; 1(1):53-60. PubMed ID: 18393780
[TBL] [Abstract][Full Text] [Related]
18. Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
Gutzmer R; Wiegand S; Kölbl O; Wermker K; Heppt M; Berking C
Dtsch Arztebl Int; 2019 Sep; 116(37):616-626. PubMed ID: 32048593
[TBL] [Abstract][Full Text] [Related]
19. Updates on Treatment Approaches for Cutaneous Field Cancerization.
Huang A; Nguyen JK; Austin E; Mamalis A; Jagdeo J
Curr Dermatol Rep; 2019 Sep; 8(3):122-132. PubMed ID: 31475077
[TBL] [Abstract][Full Text] [Related]
20. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.
Couch SM; Custer PL
Ophthalmic Plast Reconstr Surg; 2012; 28(3):181-3. PubMed ID: 22460673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
